Recent advances in understanding colorectal cancer [version 1; referees: 2 approved]

by Sebastian Stintzing
Published 2018-09-01

Patient Selection Approaches in FGFR Inhibitor Trials—Many Paths to the Same End?

by Peter Ellinghaus, Daniel Neureiter, Hendrik Nogai, Sebastian Stintzing, Matthias Ocker
Published 2022-10-01

Immunmodulatory Treatment Strategies of Hepatocellular Carcinoma: From Checkpoint Inhibitors Now to an Integrated Approach in the Future

by Matthias Ocker, Christian Mayr, Tobias Kiesslich, Sebastian Stintzing, Daniel Neureiter
Published 2021-03-01

ESMO management and treatment adapted recommendations in the COVID-19 era: colorectal cancer

by George Pentheroudakis, Loredana Vecchione, Jean-Yves Douillard, Florian Lordick, Sebastian Stintzing
Published 2020-11-01

Myelodysplastic Syndrome and Histone Deacetylase Inhibitors: “To Be or Not to Be Acetylated”?

by Sebastian Stintzing, Ralf Kemmerling, Tobias Kiesslich, Beate Alinger, Matthias Ocker, Daniel Neureiter
Published 2011-01-01

Ferroptosis in Hepatocellular Carcinoma: Mechanisms, Drug Targets and Approaches to Clinical Translation

by Dino Bekric, Matthias Ocker, Christian Mayr, Sebastian Stintzing, Markus Ritter, Tobias Kiesslich, Daniel Neureiter
Published 2022-04-01

Next-Generation CEA-CAR-NK-92 Cells against Solid Tumors: Overcoming Tumor Microenvironment Challenges in Colorectal Cancer

by Alexander Sebastian Franzén, Abdelhadi Boulifa, Clarissa Radecke, Sebastian Stintzing, Martin J. Raftery, Gabriele Pecher
Published 2024-01-01

Rechallenge with anti-EGFR therapy to extend the continuum of care in patients with metastatic colorectal cancer

by Chiara Cremolini, Clara Montagut, Philippe Ronga, Filippo Venturini, Kensei Yamaguchi, Sebastian Stintzing, Alberto Sobrero
Published 2023-02-01

Distinguishing Features of Cetuximab and Panitumumab in Colorectal Cancer and Other Solid Tumors

by Jesús García-Foncillas, Yu Sunakawa, Dan Aderka, Zev Wainberg, Philippe Ronga, Pauline Witzler, Sebastian Stintzing
Published 2019-09-01

Survey of Long-Term Experiences of Sperm Cryopreservation in Oncological and Non-Oncological Patients: Usage and Reproductive Outcomes of a Large Monocentric Cohort

by Nadine Lackamp, Ina Wilkemeyer, Ivan Jelas, Ulrich Keller, Lars Bullinger, Sebastian Stintzing, Philipp le Coutre
Published 2021-11-01

Role of beta-(1→3)(1→6)-D-glucan derived from yeast on natural killer (NK) cells and breast cancer cell lines in 2D and 3D cultures

by Abdelhadi Boulifa, Martin J. Raftery, Alexander Sebastian Franzén, Clarissa Radecke, Sebastian Stintzing, Jens-Uwe Blohmer, Gabriele Pecher
Published 2024-03-01

PD-L1 Amino Acid Position 88 Represents a Hotspot for PD-L1 Stability With Relevance for PD-L1 Inhibition

by Luise Victoria Claaß, Christoph Schultheiß, Rebekka Scholz, Lisa Paschold, Donjete Simnica, Volker Heinemann, Sebastian Stintzing, Mascha Binder
Published 2022-07-01

Long‐term observation of the frequency of secondary colorectal cancer and other malignancies in tyrosine kinase inhibitor treated chronic myeloid leukemia patients and controls

by Nina Winkelmann, Michaela Schwarz, Bert Hildebrandt, Oliver Henke, Lars Bullinger, Il‐Kang Na, Sebastian Stintzing, Philipp le Coutre
Published 2022-08-01

Next Generation CD44v6-Specific CAR-NK Cells Effective against Triple Negative Breast Cancer

by Martin J. Raftery, Alexander Sebastian Franzén, Clarissa Radecke, Abdelhadi Boulifa, Günther Schönrich, Sebastian Stintzing, Jens-Uwe Blohmer, Gabriele Pecher
Published 2023-05-01

Impact of Smoking, Body Weight, Diabetes, Hypertension and Kidney Dysfunction on Survival in Pancreatic Cancer Patients—A Single Center Analysis of 2323 Patients within the Last De...

by Christopher C. M. Neumann, François Schneider, Georg Hilfenhaus, Loredana Vecchione, Christian Benzing, Jana Ihlow, Uli Fehrenbach, Thomas Malinka, Ulrich Keilholz, Sebastian Stintzing, Uwe Pelzer
Published 2023-05-01

Amphiregulin (AREG) and Epiregulin (EREG) Gene Expression as Predictor for Overall Survival (OS) in Oxaliplatin/Fluoropyrimidine Plus Bevacizumab Treated mCRC Patients—Analysis of...

by Sebastian Stintzing, Boryana Ivanova, Boryana Ivanova, Ingrid Ricard, Andreas Jung, Thomas Kirchner, Andrea Tannapfel, Hendrik Juette, Susanna Hegewisch-Becker, Dirk Arnold, Anke Reinacher-Schick
Published 2018-11-01

Safety, Efficacy and Pharcacokinetics of Targeted Therapy with The Liposomal RNA Interference Therapeutic Atu027 Combined with Gemcitabine in Patients with Pancreatic Adenocarcinom...

by Beate Schultheis, Dirk Strumberg, Jan Kuhlmann, Martin Wolf, Karin Link, Thomas Seufferlein, Joerg Kaufmann, Mathilde Feist, Frank Gebhardt, Mike Khan, Sebastian Stintzing, Uwe Pelzer
Published 2020-10-01

Inflammation-Based Prognostic Scores in Pancreatic Cancer Patients—A Single-Center Analysis of 1294 Patients within the Last Decade

by Christopher C. M. Neumann, François Schneider, Georg Hilfenhaus, Loredana Vecchione, Matthäus Felsenstein, Jana Ihlow, Dominik Geisel, Steffen Sander, Johann Pratschke, Sebastian Stintzing, Ulrich Keilholz, Uwe Pelzer
Published 2023-04-01

EMT-Related Genes Have No Prognostic Relevance in Metastatic Colorectal Cancer as Opposed to Stage II/III: Analysis of the Randomised, Phase III Trial FIRE-3 (AIO KRK 0306; FIRE-3)

by Elise Pretzsch, Volker Heinemann, Sebastian Stintzing, Andreas Bender, Shuo Chen, Julian Walter Holch, Felix Oliver Hofmann, Haoyu Ren, Florian Bösch, Helmut Küchenhoff, Jens Werner, Martin Konrad Angele
Published 2022-11-01

Cachexia-Affected Survival Based on Inflammatory Parameters Compared to Complex Conventional Nutritional Assessments in Patients with Pancreatic Cancer and Other Gastrointestinal T...

by Johanna W. Meyer-Knees, Janina Falkenthal, Dominik Geisel, Christopher C. M. Neumann, Georg Hilfenhaus, Lars U. Stephan, Wenzel Schöning, Thomas Malinka, Johann Pratschke, Sebastian Stintzing, Uwe Pelzer
Published 2024-03-01